2Ganz PA,Figlin RA,Haskell CM,et al. supportive care and chemotherapy in a metastatic non-small cell lung cancer: Doses chemotherapy make a difference[J].Cancer,1998,63:1271.
3Chevalier TL, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Resykts if a Eyrioeab nyktucebter truak ubckydubg 612 oatuebts [J]. J Clin Oncol, 1994, 12: 360.
4Bunn PA, Soriano AF. Chemother-apeutic optionns in lung cancer [J].cancer,1998,33(8):1740.
5Brooks BJ, Cralla RJ,Mc Caw HJ, et al. Cisplatin+VR(NVB) combination chemotheraphy for advanced NSCLC; Testing the efficacy of a regimen designed to reduce toxicity and increase dose intensity[J]. proc Am Soc Oncol, 1994,13:348.
3Lin PC,Wang WS,Yang MH,et al. Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/tax- ane-refractory metastatic breast cancer [J]. J Chin Med Assoc, 2006,69 ( 7 ) : 304-309.
